How Farid was paid
$4.1M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Ramy FaridPresident and Chief Executive Officer | $730,000 | — | $796,500 | $1,966,876 | $570,860 | $14,807 | $4,079,043 |
| Richie JainChief Financial Officer | $503,747 | $588,513 | $459,462 | $231,901 | — | $12,306 | $1,795,930 |
| Geoffrey PorgesChief Financial Officer | $317,714 | — | $265,500 | $667,860 | — | $770,837 | $2,021,911 |
| Karen AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | $600,000 | — | $331,875 | $834,824 | $331,200 | $13,025 | $2,110,924 |
| Mannix AklianChief Commercial Officer, Global Head of Software Sales & Marketing | $286,685 | $75,000 | $301,511 | $1,153,675 | $180,034 | $14,471 | $2,011,376 |
| Yvonne TranChief Legal Officer and Chief People Officer | $584,000 | — | $265,500 | $667,859 | $268,640 | $14,807 | $1,800,806 |
What changed and why
- $255.9MTotal revenue for 2025 reached $255.9 million, representing a 23.3 percent increase over 2024.
- $4.4MCEO total compensation decreased from $4,407,100 in 2024 to $4,079,043 in 2025.
- 94%Stockholder support for the say-on-pay vote exceeded 94 percent at the 2025 annual meeting.
- Richie Jain was appointed as chief financial officer effective May 16, 2025.
- Performance-based restricted stock units were granted to all executive officers for 2025 performance.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.